Allspring Global Investments Holdings, LLC Vaxcyte, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 593,523 shares of PCVX stock, worth $47.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
593,523
Previous 347,474
70.81%
Holding current value
$47.3 Million
Previous $39.7 Million
22.47%
% of portfolio
0.08%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding PCVX
# of Institutions
349Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$954 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$843 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$793 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$693 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$495 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.73B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...